News
![RQ_Bio_logo](https://pharmaphorum.com/wp-content/uploads/2022/05/RQ_Bio_logo.jpg)
AstraZeneca buys into startup RQ Bio's COVID antibodies
Brand new UK startup RQ Biotechnology has been thrust into the spotlight after signing a $157 million licensing deal with AstraZeneca for monoclonal antibodies intended to protect vulnerabl